FMI Oral Solid Dosage Pharmaceutical Formulation Marke | Page 6

Oral Solid Dosage Pharmaceutical Formulation Market
Geographically, oral solid dosage pharmaceutical formulation market is segmented into regions viz. North
America, Latin America, Europe, Asia Pacific and Japan, Middle East and Africa. North America and
Europe region is projected to maintain its lions share over the forecast period. Advanced healthcare
infrastructure, availability of newer technologies and increased purchasing power is expected to propel
the demand for oral solid dosage pharmaceutical formulation during the forecast period in the above
mentioned region. Asia Pacific region is expected to be the fastest growing regional market. Growing
healthcare facilities, increased healthcare awareness in the emerging countries like India and China and
availability of skilled manpower in oral solids manufacturing are mainly generating the demand for oral
solid dosage pharmaceutical formulation products in the region.
Browse Full Report@ http://www.futuremarketinsights.com/reports/oral-solid-dosage-pharmaceutical-
formulation-market
The players in oral solid dosage pharmaceutical formulation market include AstraZeneca, Bristol-Myers
Squibb Company, Eli Lilly and Company,Gilead Sciences, Merck & Co. Inc., Novartis AG, Pfizer
Inc., AbbVie Inc. to name a few.
©2015 Future Market Insights, All Rights Reserved
6